ÂÜÀòÂÒÂ×

Caryn Mazzie is an experienced professional in the pharmaceutical industry, with a background in commercial strategy, product marketing, and financial analysis. Caryn has held various leadership roles in companies such as Ultragenyx Pharmaceutical Inc., REGENXBIO Inc., and Viela Bio, where Caryn led strategic initiatives for rare disease treatments and gene therapy programs. Caryn's expertise in launch readiness and global brand strategy has contributed to the success of innovative treatments like Evkeeza and Crysvita. Caryn also has experience as a biotech consultant and in financial planning and analysis at companies like Genentech and Abbott. With a Master of Arts degree from American University and a Bachelor of Arts in Accounting from Michigan State University, Caryn brings a wealth of knowledge and skills to their roles in the pharmaceutical industry.